[HTML][HTML] The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas

EF McCarthy - The Iowa orthopaedic journal, 2006 - ncbi.nlm.nih.gov
The Iowa orthopaedic journal, 2006ncbi.nlm.nih.gov
Abstract In 1891, William B. Coley injected streptococcal organisms into a patient with
inoperable cancer. He thought that the infection he produced would have the side effect of
shrinking the malignant tumor. He was successful, and this was one of the first examples of
immunotherapy. Over the next forty years, as head of the Bone Tumor Service at Memorial
Hospital in New York, Coley injected more than 1000 cancer patients with bacteria or
bacterial products. These products became known as Coley's Toxins. He and other doctors …
Abstract
In 1891, William B. Coley injected streptococcal organisms into a patient with inoperable cancer. He thought that the infection he produced would have the side effect of shrinking the malignant tumor. He was successful, and this was one of the first examples of immunotherapy. Over the next forty years, as head of the Bone Tumor Service at Memorial Hospital in New York, Coley injected more than 1000 cancer patients with bacteria or bacterial products. These products became known as Coley's Toxins. He and other doctors who used them reported excellent results, especially in bone and soft-tissue sarcomas.
ncbi.nlm.nih.gov